Sinovac Biotech (SVA) Common Equity (2009 - 2026)
Sinovac Biotech (SVA) reported Common Equity of $6.46 billion for Q2 2026, up 1.9% from $6.34 billion a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Sinovac Biotech posted Common Equity of $6.4 billion, down 37.9% from FY2024.
- Common Equity has declined for four consecutive years, though with a five-year compound annual growth rate of 41.4% (FY2020 to FY2025).
- By year, Common Equity came in at $10.29 billion in FY2024 (-11.6%), $11.64 billion in FY2023 (-4.9%), $12.24 billion in FY2022 (-9.7%) and $13.55 billion in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Common Equity since Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | 6.46 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.46 Bn |
| Dec 31, 2025 | 6.40 Bn |
| Jun 30, 2025 | 6.34 Bn |
| Dec 31, 2024 | 10.29 Bn |
| Jun 30, 2024 | 11.51 Bn |
| Dec 31, 2023 | 11.64 Bn |
| Jun 30, 2023 | 12.24 Bn |
| Dec 31, 2022 | 12.24 Bn |
| Jun 30, 2022 | 14.09 Bn |
| Dec 31, 2021 | 13.55 Bn |
| Jun 30, 2021 | 9.13 Bn |
| Dec 31, 2020 | 1.13 Bn |
| Sep 30, 2020 | 377.25 Mn |
| Jun 30, 2020 | 337.99 Mn |
| Mar 31, 2020 | 339.50 Mn |
| Dec 31, 2019 | 352.20 Mn |
| Sep 30, 2019 | 313.67 Mn |
| Jun 30, 2019 | 311.79 Mn |
| Mar 31, 2019 | 300.29 Mn |
| Dec 31, 2018 | 291.93 Mn |
API Access
Sinovac Biotech Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();